Fludarabine may overcome resistance to rituximab in IgM-related neuropathy

Journal of the Neurological Sciences

Volumn 315, Issue 1-2, 2012, Pages 150-152

  Koya, Junji ^a   Iwata, Atsushi ^a   Nakamura, Fumihiko ^a   Nagashima, Yu ^a   Ichikawa, Motoshi ^a   Tsuji, Shoji ^a   Kurokawa, Mineo ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Combination drug therapy; Drug resistance; Fludarabine; IgM related neuropathy; Rituximab; Waldenstr m macroglobulinaemia

Indexed keywords

ANTIBODY; ANTIMYELIN ANTIBODY; ANTISULPHATE 3 GLUCURONYL PARAGLOBOSIDE ANTIBODY; FLUDARABINE; GLYCOPROTEIN; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN M KAPPA LIGHT CHAIN; RITUXIMAB; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CASE REPORT; CELL PROLIFERATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DRUG TOLERABILITY; ELECTRON MICROSCOPY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOELECTROPHORESIS; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LEUKOPENIA; LYMPHADENOPATHY; MALE; MONOTHERAPY; MOTOR DYSFUNCTION; MULTIPLE CYCLE TREATMENT; MUSCLE ACTION POTENTIAL; MUSCLE ATROPHY; MUSCLE WEAKNESS; NAUSEA; NERVE BIOPSY; NEURALGIA; NEUROPATHY; PARESTHESIA; PLASMAPHERESIS; PRIORITY JOURNAL; WALDENSTROEM MACROGLOBULINEMIA;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; POLYNEUROPATHIES; VIDARABINE;

EID: 84857996391     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.12.001     Document Type: Article

References (15)

1. Kuijf ML, Eurelings M, Tio-Gillen AP, van Doorn PA, van den Berg LH, Hooijkaas H, et al. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy. Neurology Sep 1 2009;73(9):688-95.
2. Comi G, Roveri L, Swan A, Willison H, Bojar M, Illa I, et al. A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. J Neurol Oct 2002;249(10):1370-7. (Pubitemid 35217657)
3. Dyck PJ, Low PA, Windebank AJ, Jaradeh SS, Gosselin S, Bourque P, et al. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med Nov 21 1991;325(21):1482-6.
4. DalakasMC, RakocevicG, SalajeghehM, Dambrosia JM, Hahn AF, Raju R, et al. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy. Ann Neurol Mar 2009;65(3):286-93.
5. Noronha V, Fynan TM, Duffy T. Flare in neuropathy following rituximab therapy for Waldenstrom's macroglobulinemia. J Clin Oncol Jan 1 2006;24(1):e3.
6. Stolz C, Schuler M. Molecular mechanisms of resistance to rituximab and pharmacologic strategies for its circumvention. Leuk Lymphoma Jun 2009;50(6):873-85.
7. Hiraga J, Tomita A, Sugimoto T, Shimada K, Ito M, Nakamura S, et al. Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance. Blood May 14 2009;113(20):4885-93.
8. Rojas-Garcia R, Gallardo E, de Andres I, de Luna N, Juarez C, Sanchez P, et al. Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximab. Neurology Dec 23 2003;61(12):1814-6. (Pubitemid 38020840)
9. Pestronk A, Florence J, Miller T, Choksi R, Al-Lozi MT, Levine TD. Treatment of IgM antibody associated polyneuropathies using rituximab. J Neurol Neurosurg Psychiatry Apr 2003;74(4):485-9. (Pubitemid 36379372)
10. Dhodapkar MV, Jacobson JL, Gertz MA, Crowley JJ, Barlogie B. Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: an update of a US intergroup trial (SW0G S9003). Semin Oncol Apr 2003;30(2):220-5. (Pubitemid 36506313)
11. Peinert S, TamCS, Prince HM, Scarlett J,WolfMM, Januszewicz EH, et al. Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenstrom macroglobulinemia. Leuk Lymphoma Dec 2010;51(12):2188-97.
12. Niermeijer JM, Eurelings M, Lokhorst H, Franssen H, Fijnheer R, Wokke JH, et al. Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy. Neurology Dec 12 2006;67(11):2076-9. (Pubitemid 44967398)
13. Di Gaetano N, Xiao Y, Erba E, Bassan R, Rambaldi A, Golay J, et al. Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone. Br J Haematol Sep 2001;114(4):800-9. (Pubitemid 32953735)
14. Czuczman MS, Koryzna A, Mohr A, Stewart C, Donohue K, Blumenson L, et al. Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma. J Clin Oncol Feb 1 2005;23(4):694-704. (Pubitemid 46224168)
15. Gruson B, Ghomari K, Beaumont M, Garidi R, Just A, Merle P, et al. Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy. J Peripher Nerv Syst Sep 2011;16(3):180-5.